标题
The CDK inhibitors in cancer research and therapy
作者
关键词
-
出版物
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 137, Issue 10, Pages 1409-1418
出版商
Springer Nature
发表日期
2011-08-30
DOI
10.1007/s00432-011-1039-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
- (2011) J. E. Karp et al. BLOOD
- A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer
- (2010) Houman M. Fekrazad et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
- (2010) Christophe Le Tourneau et al. EUROPEAN JOURNAL OF CANCER
- Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
- (2010) W. Blum et al. HAEMATOLOGICA
- Cyclin D3/CDK11p58 Complex Involved in Schwann Cells Proliferation Repression Caused by Lipopolysaccharide
- (2010) Yinong Duan et al. INFLAMMATION
- Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
- (2010) Wei-Gang Tong et al. JOURNAL OF CLINICAL ONCOLOGY
- Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions
- (2010) Sopee Poomsawat et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
- (2009) Sujee Jeon et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors
- (2009) D. Rathkopf et al. CLINICAL CANCER RESEARCH
- Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease
- (2009) Thomas S. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population
- (2009) Hyo Seon Choi et al. JOURNAL OF HUMAN GENETICS
- Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients
- (2009) W. Berkofsky-Fessler et al. MOLECULAR CANCER THERAPEUTICS
- A Phase II Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer
- (2009) Richard D. Carvajal et al. PANCREATOLOGY
- Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia
- (2008) M. A. Phelps et al. BLOOD
- An Unusual Member of the Cdk Family: Cdk5
- (2008) Fatema A. Dhariwala et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Phase I Study of Flavopiridol in Combination with Paclitaxel and Carboplatin in Patients with Non–Small-Cell Lung Cancer
- (2008) Saby George et al. Clinical Lung Cancer
- Characterization of Cyclin L1 and L2 Interactions with CDK11 and Splicing Factors
- (2008) Pascal Loyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started